![Steroid Therapy in Severe Viral Hepatitis — A Double-Blind, Randomized Trial of Methyl-Prednisolone versus Placebo | NEJM Steroid Therapy in Severe Viral Hepatitis — A Double-Blind, Randomized Trial of Methyl-Prednisolone versus Placebo | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1976/nejm_1976.294.issue-13/nejm197603252941301/20130816/images/img_medium/nejm197603252941301_t1.jpeg)
Steroid Therapy in Severe Viral Hepatitis — A Double-Blind, Randomized Trial of Methyl-Prednisolone versus Placebo | NEJM
![Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease | Scientific Reports Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-98778-z/MediaObjects/41598_2021_98778_Fig1_HTML.png)
Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease | Scientific Reports
![The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial | BMC Medicine | Full Text The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-020-01814-4/MediaObjects/12916_2020_1814_Fig2_HTML.png)
The efficacy and safety of methylprednisolone in hepatitis B virus-related acute-on-chronic liver failure: a prospective multi-center clinical trial | BMC Medicine | Full Text
![Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications | Scientific Reports Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-00368-6/MediaObjects/41598_2021_368_Fig1_HTML.png)
Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications | Scientific Reports
![Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome - Efe - 2022 - Hepatology - Wiley Online Library Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome - Efe - 2022 - Hepatology - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/7b785a82-bc55-4013-ba48-a6effc86f875/hep32572-toc-0001-m.jpg?trick=1673012591248)
Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome - Efe - 2022 - Hepatology - Wiley Online Library
![Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies ... Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies ...](https://www.thelancet.com/cms/asset/1297bd2b-eeed-414c-9262-a1fd6909b6bf/gr1.jpg)
Impact of duration of critical illness and level of systemic glucocorticoid availability on tissue-specific glucocorticoid receptor expression and actions: A prospective, observational, cross-sectional human and two translational mouse studies ...
![HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection | ACS Infectious Diseases HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection | ACS Infectious Diseases](https://pubs.acs.org/cms/10.1021/acsinfecdis.0c00638/asset/images/large/id0c00638_0007.jpeg)
HBsAg, Subviral Particles, and Their Clearance in Establishing a Functional Cure of Chronic Hepatitis B Virus Infection | ACS Infectious Diseases
![Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study - ScienceDirect Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827821004396-ga1.jpg)
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study - ScienceDirect
![DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival | Nature Communications DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33215-x/MediaObjects/41467_2022_33215_Fig1_HTML.png)
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival | Nature Communications
![Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study - Téllez - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study - Téllez - 2022 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc12f263-4475-4ea3-9efe-411e10678bcd/apt16926-toc-0001-m.jpg?trick=1671330479531)